These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2438320)

  • 21. Characterization of the excitable gap in a functionally determined reentrant circuit. Studies in the sterile pericarditis model of atrial flutter.
    Niwano S; Ortiz J; Abe H; Gonzalez X; Rudy Y; Waldo AL
    Circulation; 1994 Oct; 90(4):1997-2014. PubMed ID: 7522990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of procainamide on refractoriness, conduction, and excitable gap in canine atrial reentrant tachycardia.
    Kus T; Derakhchan K; Bouchard C; Pagé P
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1707-13. PubMed ID: 1721162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model.
    Goldstein RN; Khrestian C; Carlsson L; Waldo AL
    J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1444-50. PubMed ID: 15610294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiologic effects of N-acetylprocainamide in human beings.
    Jaillon P; Rubenson D; Peters F; Mason JW; Winkle RA
    Am J Cardiol; 1981 May; 47(5):1134-40. PubMed ID: 6164285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic effects of JTV-519, a novel cardioprotective drug, on atrial fibrillation/flutter in a canine sterile pericarditis model.
    Kumagai K; Nakashima H; Gondo N; Saku K
    J Cardiovasc Electrophysiol; 2003 Aug; 14(8):880-4. PubMed ID: 12890053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of azimilide dihydrochloride on circus movement atrial flutter in the canine sterile pericarditis model.
    Restivo M; Hegazy M; Caref EB; Avitable MJ; Assadi MA; el-Hamami M; Yin H; Piracha M; Brooks RR; el-Sherif N
    J Cardiovasc Electrophysiol; 1996 Jul; 7(7):612-24. PubMed ID: 8807407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
    Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
    Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
    Rossman EI; Liu K; Morgan GA; Swillo RE; Krueger JA; Gardell SJ; Butera J; Gruver M; Kantrowitz J; Feldman HS; Petersen JS; Haugan K; Hennan JK
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1127-33. PubMed ID: 19252062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The discordant influences of infarct healing on the electrophysiologic effects of procainamide and N-acetylprocainamide.
    Nelson SD; Coyne KS; Meimer J
    J Pharmacol Exp Ther; 1995 Apr; 273(1):315-9. PubMed ID: 7536244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of procainamide and its N-acetylated metabolite in conscious dogs with atrioventricular block: plasma concentration-response relationships.
    Boucher M; Dubray C; Paire M; Duchêne-Marullaz P
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):562-7. PubMed ID: 2447406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ranolazine terminates atrial flutter and fibrillation in a canine model.
    Bhimani AA; Yasuda T; Sadrpour SA; Khrestian CM; Lee S; Zeng D; Belardinelli L; Waldo AL
    Heart Rhythm; 2014 Sep; 11(9):1592-9. PubMed ID: 25066042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circus movement atrial flutter in the canine sterile pericarditis model. Relation of characteristics of the surface electrocardiogram and conduction properties of the reentrant pathway.
    Schoels W; Offner B; Brachmann J; Kuebler W; el-Sherif N
    J Am Coll Cardiol; 1994 Mar; 23(3):799-808. PubMed ID: 8113567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter.
    Tai CT; Chen SA; Chiang CE; Lee SH; Ueng KC; Wen ZC; Huang JL; Chen YJ; Yu WC; Feng AN; Chiou CW; Chang MS
    Circulation; 1997 Oct; 96(8):2601-11. PubMed ID: 9355900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conduction over an isthmus of atrial myocardium in vivo: a possible model of Wolff-Parkinson-White syndrome.
    Inoue H; Zipes DP
    Circulation; 1987 Sep; 76(3):637-47. PubMed ID: 3621524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A logical state model of circus movement atrial flutter role of anatomic obstacles, anisotropic conduction and slow conduction zones on induction, sustenance, and overdrive paced modulation of reentrant circuits.
    Yang H; el-Sherif N; Isber N; Restivo M
    IEEE Trans Biomed Eng; 1994 Jun; 41(6):537-48. PubMed ID: 7927373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Onset of induced atrial flutter in the canine pericarditis model.
    Shimizu A; Nozaki A; Rudy Y; Waldo AL
    J Am Coll Cardiol; 1991 Apr; 17(5):1223-34. PubMed ID: 2007723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of procainamide on the excitable gap composition in a canine model of atrial flutter.
    Jalil E; Laflamme M; Kus T
    Can J Physiol Pharmacol; 1997 Jan; 75(1):1-8. PubMed ID: 9101058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of pharmacologic agents on induced atrial flutter in dogs with right atrial enlargement.
    Boyden PA
    J Cardiovasc Pharmacol; 1986; 8(1):170-7. PubMed ID: 2419681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of class IA antiarrhythmic drugs on the reentrant circuit in common human atrial flutter.
    Ohga N; Inoue T; Doi T; Yoshida A; Yokoyama M
    Jpn Circ J; 1995 Dec; 59(12):799-807. PubMed ID: 8788371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electropharmacodynamics of N-acetylprocainamide in the immature mammalian heart--evidence for a prominent class III effect in the newborn.
    Dise T; Stolfi A; Yamasaki S; Pickoff AS
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):96-101. PubMed ID: 1708063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.